A case of alcohol withdrawal requiring 1,600 mg of lorazepam in 24 hours

CNS Spectrums

Volumn 14, Issue 7, 2009, Pages 385-389

  Kahn, Debra R ^a   Barnhorst, Amy V ^a   Bourgeois, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; LORAZEPAM;

ADULT; ARTICLE; CASE REPORT; DELIRIUM TREMENS; HOSPITALIZATION; HUMAN; MALE; TIME; TREATMENT OUTCOME;

ADULT; ALCOHOL WITHDRAWAL DELIRIUM; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350448717     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900023038     Document Type: Article

References (30)

1. Foy A, Kay J. The incidence of alcohol-related problems and the risk of alcohol withdrawal in a general hospital population. Drug Alcohol Rev. 1995;14:49-54.
2. Yost DA. Alcohol withdrawal syndrome. Am Fam Physician. 1996;54:657-664, 669.
3. Espir ML, Rose FC. Alcohol, seizures, and epilepsy. J R Soc Med. 1987;9:542-543.
4. Franklin JE, Frances RJ. Alcohol and other psychoactive substance use disorders. In: Hales RE, Yudofsky SC, eds. Essentials of Clinical Psychiatry Based on The American Psychiatric Press Textbook of Psychiatry. 3rd Ed. Washington DC: APPI; 2005:185-232.
5. Mayo-Smith MJ, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium. Arch Intern Med. 2004;164:1405-1412.
6. Ballenger JC. Benzodiazepines. In: Shatzberg AF, Nemeroff CB, eds. Essentials of Clinical Psychopharmacology. Washington, DC: APPI; 2001:75-92.
7. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on pharmacological management of alcohol withdrawal. JAMA. 1997;278:144-151.
8. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ. 1999;160:649-655. (Pubitemid 29149795)
9. Hersh D, Kranzler HR, Meyer RE. Persistent delirium following cessation of heavy alcohol consumption: diagnostic and treatment implications. Am J Psychiatry. 1997;154:846-851. (Pubitemid 27230109)
10. Hayes PC, Faestel PM, Shimanoto PL, Shimamoto PL, Holland C. Alcohol withdrawal requiring massive prolonged benzodiazepine infusion. Mil Med. 2007;172:556-559.
11. Kunkel EJS, Rodgers C, DeMaria PA, et al. Use of high dose benzodiazepines in alcohol and sedative withdrawal delirium. Gen Hosp Psychiatry. 1997;19:286-293. (Pubitemid 27400830)
12. Lineaweaver WC, Anderson K, Hing DN. Massive doses of midazolam infusion for delirium tremens without respiratory depression. Crit Care Med. 1988;16:294-295. (Pubitemid 18081914)
13. Nolop KB Natow A. Unprecedented sedative requirements during delirium tremens. Crit Care Med. 1985;13:246-247.
14. Wolf KM, Shaughnessy AF, Middleton DB. Prolonged delirium tremens requiring massive doses of medication. J Am Board Fam Pract. 1993;6:502-504.
15. Woo E, Greenblatt, DJ. Massive benzodiazepine requirements during acute alcohol withdrawal. Am J Psychiatry. 1979;136:821-823. (Pubitemid 9201194)
16. Hemmingsen R, Kramp P. Delirium tremens and related clinical states: psychopathology, cerebral pathophysiology and psychochemistry: a two-component hypothesis concerning etiology and pathogenesis. Acta Psychiatr Scand Suppl. 1988;354:94-107. (Pubitemid 18228018)
17. Cagetti E, Liang J, Spigelman I, Olsen RW. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAa receptors. Mol Pharmacol. 2003;63:53-64. (Pubitemid 36043808)
18. Rogawski MA. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr. 2005;5:225-230.
19. Davis KM, We-JY. Role of glutamatergic and GABAergic systems in alcoholism. J Biomed Sci. 2001;8:7-19.
20. Krupitsky EM, Rudenko AA, Burakov AM, et al. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res. 2007;31:604-611.
21. Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and Phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35:724-730. (Pubitemid 46407784)
22. McCowan C, Mark P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med. 2000;28:1781-1784. (Pubitemid 30428729)
23. Coomes TR, Smith SW. Successful use of propofol in refractory delirium tremens. Ann Emerg Med. 1997;30:825-828.
24. Ninan PT, Cole JO, Yonders KA. Nonbenzodiazepine anxiolytics. In: Shatzberg AF, Nemeroff CB, eds. Essentials of Clinical Psychopharmacology. Washington, DC: APPI; 2001:93-102.
25. Metten P, Crabbe JC. Genetic determinants of severity of acute withdrawal from diazepam in mice: commonality with ethanol and pentobarbital. Pharmacol Biochem Behav. 1999;63:473-479. (Pubitemid 29287166)
26. Van Munster BC, Korevaar JC, de Rooij SE, Levi M, Zwinderman AH. Genetic polymorphisms related to delirium tremens: a systematic review. Alcohol Clin Exp Res. 2007;31:177-184. (Pubitemid 46155216)
27. Preuss UW, Zill P, Koller G. Ionotropic glutamate receptor gene GRIK3 SER310ALA functional polymorphism is related to delirium tremens in alcoholics. Pharmacogenomics J. 2006;6:34-41. (Pubitemid 43118309)
28. Carta M, Ariwodola OJ, Weiner JL, Valenzuela CF. Alcohol potently inhibits the kainite receptor-dependent excitatory drive of hippocampal interneurons. Proc Natl Acad Sci USA. 2003;100:6813-6818. (Pubitemid 36666662)
29. Lum E, Gorman SK, Slavik RS. Valproic acid management of acute alcohol withdrawal. Ann Pharmacother. 2006;40:441-448.
30. Polycarpou A, Papanikalaou P, Ioannidis J, Contopoulos-Ioannidis DG. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2005;3:CD005064.